|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 09-15 | Vericel Corporation Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 02:35 PM | |
| 07-31 | Truist Raises Price Target on Vericel to $58 From $54, Keeps Buy Rating | MT |
Stock exchange
Basic data
Market Cap (USD)
2,079,500,594
Net sales (USD)
276,259,000
Free-Float
98.81%
Free-Float capitalization (USD)
2,054,748,677
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 2.08B | |
| +3.13% | +11.45% | +703.24% | +96.98% | 81.23B | |
| -0.23% | -6.64% | +33.84% | -8.80% | 74.94B | |
| +1.05% | +2.78% | -7.05% | -25.22% | 60.9B | |
| -1.07% | -0.43% | -10.19% | +32.27% | 47.22B | |
| -0.58% | -2.88% | -12.55% | +164.00% | 44.68B | |
| -0.71% | +0.76% | +63.93% | -11.65% | 33.55B | |
| -1.30% | -2.94% | +46.86% | +113.26% | 24.97B | |
| +0.53% | 0.00% | +53.28% | +95.55% | 15.17B | |
| -0.96% | -4.71% | +26.96% | +150.17% | 12.9B | |
| Average | -0.54% | -0.91% | +99.81% | +67.40% | 39.76B | |
| Weighted average by Cap. | -0.53% | +0.35% | +158.41% | +51.46% |
Historical Quotes: Aastrom Biosciences Inc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- VCEL Stock
- Stock
- Quotes Aastrom Biosciences Inc
Select your edition
All financial news and data tailored to specific country editions
